Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Short Interest Down 96.3% in February

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSCGet Free Report) was the recipient of a large decrease in short interest during the month of February. As of February 27th, there was short interest totaling 1,207 shares, a decrease of 96.3% from the February 12th total of 32,799 shares. Based on an average daily volume of 57,880 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 57,880 shares, the days-to-cover ratio is presently 0.0 days.

Cardiac Biotech Solutions Stock Performance

Shares of CBSC stock opened at $0.04 on Thursday. Cardiac Biotech Solutions has a fifty-two week low of $0.02 and a fifty-two week high of $0.08. The stock’s fifty day moving average is $0.04 and its two-hundred day moving average is $0.04.

About Cardiac Biotech Solutions

(Get Free Report)

CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

See Also

Receive News & Ratings for Cardiac Biotech Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiac Biotech Solutions and related companies with MarketBeat.com's FREE daily email newsletter.